Gynecologic and reproductive issues in women on dialysis

American Journal of Kidney Diseases

Volumn 29, Issue 5, 1997, Pages 685-690

  Holley, Jean L ^a   Schmidt, Rebecca J ^b   Bender, Filitsa H ^b   Dumler, Francis ^b   Schiff, Melissa ^b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b NONE

Author keywords

Amenorrhea; end stage renal disease; estrogen replacement; sexuality

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ADULT; ARTICLE; ATHEROSCLEROSIS; CONTRACEPTION; DIALYSIS; ESTROGEN THERAPY; FEMALE; HORMONAL REGULATION; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; MENSTRUAL CYCLE; OSTEOPOROSIS; PREGNANCY; REPRODUCTION; SEXUAL BEHAVIOR; SEXUAL FUNCTION;

EID: 0030963132     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(97)90120-7     Document Type: Article

References (23)

1. Lim VS: Reproductive function in patients with renal insufficiency. Am J Kidney Dis 9:363-367, 1987
2. Lim VS, Henriquez C, Sievertson G, Frohman LA: Ovarian function in chronic renal failure: Evidence suggesting hypothalamic anovulation. Ann Intern Med 93:21-27, 1980
3. Gómez F, De La Cueva R, Wauters J-P, Lemarchand-Béraud T: Endocrine abnormalities in patients undergoing long-term hemodialysis: The role of prolactin. Am J Med 68:522-530, 1980
4. Gilbaro SD, Delano BG, Quinn R, Lundin AP, Galonsky R, Friedman EA: Improved quality of life while receiving recombinant erythropoietin (Epoetin alfa). Kidney Int 35:247, 1989 (abstr)
5. Schafer RM, Kokot F, Wernze H, Geiger H, Heidland A: Improved sexual function in hemodialysis patients on recombinant erythropoietin: A possible role for prolactin. Clin Nephrol 31:1-5, 1989
6. Delano BG: Improvements in quality of life following treatment with r-HuEpo in anemic hemodialysis patients. Am J Kidney Dis 14:14-18, 1989 (suppl 1)
7. Mastrogiacomo I, DeBesi L, Serafini E, Zussa P, Romagnoli GF, Saporiti E, Dean P, Ronco C, Adami A: Hyperprolactinemia and sexual disturbances among uremic women on hemodialysis. Nephron 37:195-199, 1984
8. Rozenman D, Gurewicz S, Blickstein I, Shoham Z, Bar-Khayim Y: Sexual function of women on dialysis. Dial Transplant 19:640-644, 1990
9. Binik YM, Mah K: Sexuality and end-stage renal disease: Research and clinical recommendations. Adv Renal Replac Ther 1:198-209, 1994
10. Stout JP, Auer J, Kincey J, Hillier VF, Gokal R, Simon LG, Oliver D: Sexual and marital relationships and dialysis - The patient's viewpoint. Perit Dial Bull 7:97-100, 1987
11. Finkelstein FO, Finkelstein SH, Steele TE: Assessment of marital relationships of hemodialysis patients. Am J Med Sci 271:21-28, 1976
12. Sievertson GD, Lim VS, Nakawatase C, Frohman LA: Metabolic clearance and secretion rates of human prolactin in normal subjects and in patients with chronic renal failure. J Clin Endocrinol Metab 50:846-852, 1980
13. Kokot F, Wiecek A, Gzreszczak W, Klin M: Influence of erythropoietin treatment on follitropin and lutropin response to luliberin and plasma testosterone levels in hemodialyzed patients. Nephron 56:126-129, 1990
14. Tsakiris D, Visvardis G, Papadopoulou D, Papadimitriou M: Study of endocrine function in patients under haemodialysis during therapy with erythropoietin. Kidney Int 44:912, 1993 (abstr)
15. Evans RW, Rader B, Manninen DL, Cooperative Multicenter EPO Clinical Trials Group: The quality of life of hemodialysis recipients treated with recombinant human erythropoietin. JAMA 263:825-830, 1990
16. Carr BR, Wilson JD: Disorders of the ovary and female reproductive tract, in Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL (eds): Harrison's Principles of Internal Medicine (ed 13). New York, NY, McGraw-Hill, 1994, pp 2017-2036
17. Milde FK, Hart LK, Fearing MO, Cox DM: A survey of patient sexual education programs in US renal transplant and dialysis centers. Dial Transplant 23:306-312, 1994
18. Holley JL, Nespor SL: Nephrologist-directed primary health care in chronic dialysis patients. Am J Kidney Dis 21:628-631, 1993
19. Sloand JA, Schiff MJ: Beneficial effect of low-dose transdermal estrogen on bleeding time and clinical bleeding in uremia. Am J Kidney Dis 26:22-26, 1995
20. Lufkin EG, Wahner HW, O'Fallon WM, Hodgson SF, Kotowicz MA, Lane AW, Judd HL, Caplan RH, Riggs BL: Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med 117:1-9, 1992
21. Stampfer MJ, Willett WC, Coldwitz GA, Rosner B, Speizer FE, Hennekens CH: A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med 313:1044-1049, 1985
22. Sullivan JM, Vander Zwaag R, Lemp GF, Hughes JP, Maddock V, Kroetz FW, Ramanathan KB, Mirvis DM: Postmenopausal estrogen use and coronary atherosclerosis. Ann Intern Med 108:358-363, 1988
23. Ritz E, Querfeld U: Atherogenesis - Is it acelerated in uremia? Semin Dial 2:246-252, 1989